Navigation Links
Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
Date:10/23/2007

--FDA Has Agreed That Positive Survival Data from IMPACT Study Would

Support Licensure of PROVENGE-

--Interim Survival Results Expected in Second Half of 2008--

SEATTLE, Oct. 23 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that the Company has completed enrollment of over 500 patients in the Phase 3 IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment, also known as D9902B) clinical trial of PROVENGE (sipuleucel-T), the Company's investigational active cellular immunotherapy for the treatment of advanced prostate cancer. The IMPACT study is a double-blind, randomized, placebo-controlled Phase 3 trial designed to measure overall survival in men with metastatic hormone-refractory prostate cancer receiving PROVENGE versus placebo.

Earlier this year, following a positive recommendation from an outside panel of experts, Dendreon received a complete response letter from the U.S. Food and Drug Administration (FDA) that asked for additional evidence that would support the efficacy of PROVENGE. Subsequently, Dendreon received confirmation that the FDA will accept either a positive interim or positive final analysis of overall survival from the IMPACT study to amend the Biologics License Application (BLA) and support the efficacy claim for PROVENGE.

"The completion of enrollment of over 500 patients into the IMPACT study is a major achievement for the organization, as the data from this trial may provide the FDA with the additional clinical data they need for the approval of PROVENGE," said Mitchell H. Gold, M.D., president and chief executive officer of Dendreon. "Men with late stage prostate cancer currently have few appealing treatm
'/>"/>

SOURCE Dendreon Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Presentation of Data at American Urological Association Annual Meeting
2. Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
3. Celsion Completes Enrollment in Phase I Liver Cancer Study
4. LANI completes Phase I in Japan and to commence Phase I in UK
5. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
6. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
7. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
8. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
9. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
10. Two Phase III clinical trials on corifollitropin alfa (Org 36286) reach randomization target
11. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... and CARDIFF-BY-THE-SEA, Calif. , ... SRNE ;  Sorrento), an oncology company ... and Conkwest, Inc., a privately-held immuno-oncology company developing ... (NK) cell-line based therapy, announced today that the ... jointly develop next generation CAR-TNK™ (pronounced as "Car-Tank") ...
(Date:12/19/2014)... Dec. 18, 2014  Sage Analytics ( www.sageanalytics.com ... equipment for the testing of marijuana potency and ... new Luminary™ Profiler, the industry,s first product suite ... a cost-effective, portable unit. Designed from ... of the cannabis industry, the Luminary™ Profiler utilizes ...
(Date:12/19/2014)... LEXINGTON, Ky. , Dec. 18, 2014 Baptist ... United States to receive full Atrial Fibrillation with ... Patient Care (SCPC). Atrial fibrillation is the most ... concern that in some cases can lead to stroke and ... the United States have atrial fibrillation and the ...
Breaking Medicine Technology:Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 2Baptist Health Lexington First in the Nation to Receive Atrial Fibrillation with EPS Accreditation 3
... 18, 2011 The National Association of Chain ... Association (NCPA) have sent a joint letter ... explaining the importance of pharmacies in Medicaid, offering ... to cut costs without endangering Medicaid beneficiaries, access ...
... Cornerstone Therapeutics Inc. (Nasdaq: CRTX ) today ... AM ET on Thursday, March 3, 2011, to discuss its ... 31, 2010. Financial results are expected to be released on ... financial markets. To participate in the live conference ...
Cached Medicine Technology:NACDS, NCPA Provide Insights to Governors and State Medicaid Directors Confronting Medicaid Budgetary Challenges 2NACDS, NCPA Provide Insights to Governors and State Medicaid Directors Confronting Medicaid Budgetary Challenges 3Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2010 Conference Call 2Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2010 Conference Call 3
(Date:12/21/2014)... New York, NY (PRWEB) December 21, 2014 ... is nearing 1,400 in a consolidated litigation underway in ... court documents, a total of 1,375 claims involving the ... County Superior Court. These lawsuits were filed by women ... claim to have led to uterine perforations and other ...
(Date:12/21/2014)... December 21, 2014 Over the past ... issues in hundreds of emergency departments across the nation, ... findings have been translated into an innovative suite of ... correct deficiencies and enhance the patient experience. , ... physician staffing and management services for hospitals, announced the ...
(Date:12/21/2014)... December 21, 2014 CannabisClassifieds.com celebrates marijuana’s new ... The only one of its kind, the site has provided ... marijuana for 14 years running. It uniquely combines the ... make cannabis readily available to the masses. Assuring the ... the golden ring of public approval. , Shane ...
(Date:12/20/2014)... BambooIndustry.com is a leading ... has announced its bamboo flooring promotion for the ... from certified suppliers, and offers the best bamboo ... the current promotion, all customers can enjoy a ... say they know BambooIndustry.com from press releases. , ...
(Date:12/20/2014)... Dress company LunaDress has recently announced its 2015 collection ... big discounts on all of its special occasion dresses & ... a perfect wedding gown. If you have no idea of ... LunaDress. Many different wedding dress styles and our dress experts ... enjoy the current special offer, up to 80% off," the ...
Breaking Medicine News(10 mins):Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 3Health News:NES Health Launches Stipend Program for Emergency Physicians in Training to Financially Assist Emergency Department Doctors While They Learn 2Health News:CannabisClassifieds.com Maintains its “Craigslist for Cannabis” Standing with Website Re-launch 2Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2
... to help improve ... health, CHICAGO, Oct. ... designed to change the way consumers think about,health care, help them lead healthier ... UniCare announced earlier this year that it would launch a new line of,consumer-driven ...
... Wedgewood Pharmacy and Midwest,Veterinary Supply, Inc. ... which Midwest will represent Wedgewood,s compounding pharmacy,services ... The relationship is,effective October 1. This is ... a,compounding pharmacy service. Through the Midwest ...
... Coverage Gap, $2 for 30-day supply of generics ... redefines value for seniors Medco Medicare ... chronic conditions that affect seniors, FRANKLIN LAKES, N.J., Oct. 1 ... While a dime can,t buy,much anymore, for millions of seniors across the ...
... Hispanic Heritage,Month in the United States and the ... has published a new and,updated Spanish version of ... launch its informative Web site (http://www.SweatHelp.org ) ... to Argentina to speak at,the 21st World Congress ...
... LANDOVER, Md., Oct. 1 The first lady of ... of her husband,s,governorship she intends to help improve the ... This week Cecile deJongh saw a major piece of ... on Wednesday and Thursday, one on St. Croix,and the ...
... ... Autism -, PHILADELPHIA, Oct. ... adults with,autism, Robert T. Schultz, Ph.D., is joining the autism research program ... ) Most recently the director of the Yale Developmental Neuroimaging,Program ...
Cached Medicine News:Health News:UniCare Introduces Consumer-Driven Health Products to Give Consumers a Bigger Role in Health Care Decisions 2Health News:UniCare Introduces Consumer-Driven Health Products to Give Consumers a Bigger Role in Health Care Decisions 3Health News:Wedgewood Pharmacy and Midwest Veterinary Supply Sign New Agency Agreement 2Health News:Wedgewood Pharmacy and Midwest Veterinary Supply Sign New Agency Agreement 3Health News:Medco Unveils Three New Medicare Prescription Drug Plan Options for 2008 to Provide Seniors More Choice, Better Value and Specialist Pharmacists 2Health News:Medco Unveils Three New Medicare Prescription Drug Plan Options for 2008 to Provide Seniors More Choice, Better Value and Specialist Pharmacists 3Health News:Medco Unveils Three New Medicare Prescription Drug Plan Options for 2008 to Provide Seniors More Choice, Better Value and Specialist Pharmacists 4Health News:In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish 2Health News:First Lady of U.S. Virgin Islands Opens New CHADD Support Groups 2Health News:Brain Imaging Expert Recruited to Study Autism at The Children's Hospital of Philadelphia 2Health News:Brain Imaging Expert Recruited to Study Autism at The Children's Hospital of Philadelphia 3
The unique design of the TWINFIX Suture Anchors combines high resistance to pullout from our patented thread design with optimal knot tying from the DURABRAID suture....
... Micro Anchor is the smallest, strongest ... flexibility in placement into even the ... with 3-0 or 4-0 ETHIBOND EXCEL ... or cutting swaged needles. The kit ...
The Mini Anchor is an exceptionally strong, versatile anchor. This anchor comes in either a load-your-own or QUICKANCHOR format, preloaded on either 2/0 or 0 ETHIBOND EXCEL suture with swaged needles...
... Threaded Anchors (3.0mm) are ideal for soft tissue ... surgical applications. The FASTIN threaded anchor technology offers ... surgical sites. If you need a threaded anchor ... the FASTIN anchor is the anchor for you. ...
Medicine Products: